Advancing Life Sciences - Innovating Health CareTM
In P. Zafiropoulos S.A. we work with a clear vision on novel therapeutic challenges !
AIGS is the fully integrated system for fast molecular diagnostics, which combines the nucleic acids extraction and realtime PCR amplification, by using the microfluidic cartridge preassembled kit to realize the fully integrated gene data analysis for the samples.
BRCAaccuTest™ & BRCAaccuTest™ PLUS is a regent for producing libraries for
analyzing the BRCA 1 & 2 genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.
The biologic drug Infliximab is a therapeutic monoclonal antibody. It acts as is an antagonist to TNF alpha, thus is effective in blocking the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN Quantum Blue® Infliximab is the first rapid test to measure infliximab trough level in patient’s serum to allow immediate decision making for potential drug dose adjustments.
MRP8/14 is an early and sensitive marker of inflammation and is released immediately in response to local inflammation. In contrast, other inflammatory markers are generated by downstream pathways and require de novo synthesis. Therefore, MRP8/14 is an ideal target for monitoring disease activity of Rheumatoid Arthritis. The MRP8/14 assays by BÜHLMANN allow for precise and sensitive measurement of this important marker.